[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359220-105":59,"doc-detail-359220-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","glioblastoma-stem-cells-and-tumour-microenvironment-interactions-across-hypoxia-vasculature-and-immune-modulation","Glioblastoma Stem Cells and Tumour Microenvironment: Interactions Across Hypoxia, Vasculature and Immune Modulation","","Glioblastoma (GBM) is an aggressive brain tumour that resists standard therapy, driven in part by a minor subpopulation of glioblastoma stem cells (GSCs). This review explains how GSCs persist and expand within protective niches, focusing on hypoxic regions that activate survival programs, perivascular areas that supply nutrients and maintain stem-like traits, and immune-related zones where inflammatory and suppressive cues enable immune escape. By linking these interacting domains, it highlights potential strategies to disrupt GSC support, curb GBM progression, and improve patient outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/glioblastoma-stem-cells-and-tumour-microenvironment-interactions-across-hypoxia-vasculature-and-immune-modulation/359220/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/glioblastoma-stem-cells-and-tumour-microenvironment-interactions-across-hypoxia-vasculature-and-immune-modulation/359220.png","ImageObject",300,407,{"name":92,"@type":93},"\tJames","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role do glioblastoma stem cells (GSCs) play in GBM treatment resistance?","Question",{"text":112,"@type":113},"GSCs drive tumour growth, invasion, and recurrence after therapy, and their survival is supported by specialized microenvironmental niches.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which microenvironmental domains are highlighted as supporting GSC persistence?",{"text":117,"@type":113},"The review focuses on hypoxic regions, perivascular (vascular) niches near blood vessels, and immune-related zones that provide inflammatory or suppressive signals.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is targeting the tumour microenvironment considered a promising therapeutic direction?",{"text":121,"@type":113},"Because the microenvironment is described as a crucial player in tumourigenesis and treatment resistance, disrupting GSC-supportive conditions may improve outcomes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359220,1790177187,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},2336474466412,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Review  \nGlioblastoma Stem Cells and Tumour Microenvironment: Interactions Across Hypoxia, Vasculature and Immune Modulation  \nKarina Biserova 1,2,* and Ilze Strumfa 1  \nAcademic Editor: Chiara Laezza  \nReceived: 1 February 2026  \nRevised: 4 March 2026  \nAccepted: 9 March 2026  \nPublished: 11 March 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Pathology, Riga Stradins University, 16 Dzirciema Street, LV-1007 Riga, Latvia; [ilze.strumfa@rsu.lv](ilze.strumfa@rsu.lv)  \n2 Pathology Institute, Riga Paul Stradins Clinical University Hospital, 13 Pilsonu Street, LV-1002 Riga, Latvia  \n* Correspondence: [karina.biserova@rsu.lv](karina.biserova@rsu.lv)  \nAbstract  \nGlioblastoma (GBM) is an aggressive brain tumour known for its ability to resist the current treatment protocols. A major reason for this resistance is a minor group of cells within the tumour called glioblastoma stem cells (GSCs) . These cells drive tumour growth, invasion, and recurrence after therapy. GSCs survive and expand within a specific microenvironment that protects and supports them. Three of the most important niches are: hypoxic (low oxygen) regions, which trigger survival pathways and make GSCs more resistant to treatment; perivascular areas near blood vessels, which provide nutrients and signals that maintain stem-like properties; and immune-related zones, where inflammatory and suppressive signals help GSCs escape the body’s defences. Together, these environments allow GSCs to thrive and contribute to the tumour’s persistence. This review highlightshow hypoxia, blood vessel niches, and immune interactions work together to sustain GSCsand promote GBM progression. A clearer understanding of these supportive environments may lead to new treatment approaches aimed at disrupting GSC survival and improving patient outcomes.  \nKeywords: cancer stem cells; glioblastoma; microenvironment; cancer  \n1. Introduction  \nGlioblastoma represents one of the most deadly malignancies in humans [1] . In the most recent edition of the WHO classification of central nervous system tumours, glioblastoma is defined as grade 4 tumour, featuring unmutated or wildtype gene of isocitrate dehydrogenase (IDH) [2] . Glioblastoma is managed by surgical resection of the tumour mass followed by radiation and chemotherapy with temozolamide [3] .  \nDespite the advances in standard treatment protocols, survival of the patients remains grim. Most individuals diagnosed with GBM have a median survival of only 14 months, with long-term survival (over five years) achieved by less than 10% of patients [4] . This underlines the urgent need to better understand the underlying biological mechanisms driving tumour growth, recurrence, and resistance to current therapies.  \nGlioblastoma stem cells—pluripotent tumour-initiating cells—are considered to be one of the key factors in glioblastoma viability and treatment resistance [5] . The therapeutic inefficacy in treating GBM is primarily due to its ability to infiltrate surrounding healthy brain tissues, blood–brain barrier, immune evasion and other complex treatment resistance mechanisms. In recent years despite molecular typing of glioblastoma tumour cells, tumour  \nmicroenvironment (TME) is considered one of the crucial players in tumorigenesis and resistance to treatment, as well as a promising therapeutic target [6,7] .  \nGBM cells engage with both cellular (such as glial cells, endothelial cells, and glioblastoma stem cells) and non-cellular components (such as the extracellular matrix and its produced molecules) of the tumour environment. Together, these elements shape tumour’s invasive and adaptive properties, fuelling its progression and making it difficult to treat effectively [8] .  \nImportant qualities of tumour-initiating microenvironment include hypoxia, which signi","cbCaidiYdPBM40EA","https://ap.wps.com/l/cbCaidiYdPBM40EA","pdf",680619,16,"English","# Introduction\n# Hypoxia—A Fertile Ground for GSC Persistence","[{\"question\":\"What role do glioblastoma stem cells (GSCs) play in GBM treatment resistance?\",\"answer\":\"GSCs drive tumour growth, invasion, and recurrence after therapy, and their survival is supported by specialized microenvironmental niches.\"},{\"question\":\"Which microenvironmental domains are highlighted as supporting GSC persistence?\",\"answer\":\"The review focuses on hypoxic regions, perivascular (vascular) niches near blood vessels, and immune-related zones that provide inflammatory or suppressive signals.\"},{\"question\":\"Why is targeting the tumour microenvironment considered a promising therapeutic direction?\",\"answer\":\"Because the microenvironment is described as a crucial player in tumourigenesis and treatment resistance, disrupting GSC-supportive conditions may improve outcomes.\"}]","Glioblastoma Stem Cells and Tumour Microenvironment: Interactions Across Hypoxia, Vasculature and Immune Modulation | PDF",1790136452,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9e79d2e39ac659599f1166f0f80207ab.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ca31058488cd77e3e44dd36ada351e9.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/100ee20a23b110b8362b40c3a72aab9b.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/32d4e76c6f685ca53821cb8f3c602598.webp",980,1385]